• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Introgen Therapeutics Inc


Ticker Delisted

Company Profile for Introgen Therapeutics Inc (INGNQ)

Introgen Therapeutics, Inc. develops gene therapy products for the treatment of cancer. The Company's lead product candidate combines the p53 gene, a tumor suppressor gene, with a gene delivery system that it has developed and tested. Introgen is developing cancer therapies which are based on restoring normal cellular function through gene therapy.

Contact Information

Introgen Therapeutics Inc

301 Congress Avenue
Suite 1850
Austin, TX 78701
United States
Phone: 1-512-708-9310
Fax: 1-512-708-9311

Key Executives for Introgen Therapeutics Inc (INGNQ)

Kerstin B MenanderVP:Clinical DevelopmentRodney VarnerSecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil